Clevira, an antiviral formulation receives GOIs regulatory approval as a supportive treatment for mild to moderate COVID-19 cases
India, 30 April 2021: Apex Laboratories Private Limited, a Chennai based pharmaceutical company known for its cutting-edge research and innovation, introduces Clevira, an antiviral herbal formulation.
Clevira was developed primarily to treat dengue patients in 2017. Last year as the COVID-19 cases surged in the country, it was repurposed as…
Read More...